Skadden Advises Endo In $168M Penwest Buy
Endo Pharmaceuticals Inc. has announced plans to acquire Penwest Pharmaceuticals Co. — its partner in developing painkiller Opana ER — in a cash tender offer valued at $168 million....To view the full article, register now.
Already a subscriber? Click here to view full article